Danish allergy immunotherapy specialist ALK has announced that the UK’s Medicines and Healthcare Products Regulatory Agency ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

The European Medicines Agency has called for updated rules and processes to reflect growing use of artificial intelligence in ...

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

A panel of health experts has called on the US regulator to remove boxed warnings from vaginal estrogen treatments, arguing the safety notice is no longer backed by current evidence and discourages ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...

US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

Once seen as a niche tool for rare tumors, theranostics is quickly becoming a new standard in cancer care. Combining diagnostics and therapy in a single platform, the field has drawn billions in ...